Screener
Acadia Pharmaceuticals ACAD Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 1,224,545 | 1,062,113 |
| Property and equipment, net | 17,107 | 7,511 |
| Operating lease right-of-use assets | 69,424 | 47,354 |
| Intangible assets, net | 103,448 | 108,893 |
| Restricted cash | 7,846 | 7,845 |
| Long-term inventory | 76,301 | 76,704 |
| Deferred tax assets | 240,679 | 249,879 |
| Other assets | 3,550 | 3,896 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's intangibles (net)?
- Acadia Pharmaceuticals (ACAD) reported intangibles (net) of $103.45M in Q2 2026.
- How has Acadia Pharmaceuticals's intangibles (net) changed year-over-year?
- Acadia Pharmaceuticals's intangibles (net) decreased by 9.5% year-over-year, from $114.34M to $103.45M.
- What is the long-term trend for Acadia Pharmaceuticals's intangibles (net)?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's intangibles (net) has grown at a 150.3% compound annual growth rate (CAGR), from $1.11M to $108.89M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Acadia Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude